These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28166667)

  • 41. Diagnosis of Wilson's disease presenting as fulminant hepatic failure.
    McCullough AJ; Fleming CR; Thistle JL; Baldus WP; Ludwig J; McCall JT; Dickson ER
    Gastroenterology; 1983 Jan; 84(1):161-7. PubMed ID: 6847842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on azide, caeruloplasmin and copper in relation to Wilson's disease.
    Williams AO
    Br J Exp Pathol; 1967 Apr; 48(2):180-7. PubMed ID: 6022752
    [No Abstract]   [Full Text] [Related]  

  • 43. Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis.
    Ilan Y; Hillman M; Oren R; Galun E; Shalit M
    Gut; 1991 May; 32(5):549-50. PubMed ID: 2040480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease.
    Walshe JM
    Mov Disord; 2005 Dec; 20(12):1658-61. PubMed ID: 16092117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Wilson's disease--a factor in the differential diagnosis in hepatopathies].
    Dastych M; Jezek P; Snelerová M
    Vnitr Lek; 1989 Jul; 35(7):695-700. PubMed ID: 2800377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between the concentrations of trichloroacetic acid-soluble copper and caeruloplasmin in the serum of cattle from areas with different soil concentrations of molybdenum.
    Suttle NF
    Vet Rec; 2008 Feb; 162(8):237-40. PubMed ID: 18296665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of the caeruloplasmin gene in the adult and neonatal rat liver.
    Barrow L; Tanner MS; Critchley DR
    Clin Sci (Lond); 1989 Sep; 77(3):259-63. PubMed ID: 2805592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus.
    Logan JI; Harveyson KB; Wisdom GB; Hughes AE; Archbold GP
    QJM; 1994 Nov; 87(11):663-70. PubMed ID: 7820540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoceruloplasminemia and ultrastructural changes resembling Wilson's disease in nonalcoholic liver steatosis. A clinical and pathological study of five cases.
    Geubel AP; Gregoire V; Rahier J; Lissens W; Dive C
    Liver; 1988 Oct; 8(5):299-306. PubMed ID: 3200124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients.
    Roxborough HE; Mercer C; McMaster D; Maxwell AP; Young IS
    Nephron; 2000 Mar; 84(3):211-7. PubMed ID: 10720890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case report on Wilson's disease.
    Rahman S; Siddiqui NI; Paul GK; Sarker CB; Rahman KM
    Mymensingh Med J; 2003 Jul; 12(2):142-5. PubMed ID: 12894051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Early diagnosis of Wilson's disease in childhood (author's transl)].
    Feist D; Wesch H; Schmid-Rüter E
    Monatsschr Kinderheilkd (1902); 1978 Jun; 126(6):371-4. PubMed ID: 661832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automated determination of serum ceruloplasmin activity with o-dianisidine dihydrochloride as substrate.
    Schosinsky KH; Lehmann HP; Beeler MF
    Clin Chem; 1975 May; 21(6):757-9. PubMed ID: 1122621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caeruloplasmin: a plasma protein, enzyme, and antioxidant.
    Gutteridge JM
    Ann Clin Biochem; 1978 Nov; 15(6):293-6. PubMed ID: 736489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum micronutrient and micromineral concentrations and ratios in healthy Omani subjects.
    Abiaka C; Al-Tobi M; Joshi R
    Med Princ Pract; 2008; 17(4):334-9. PubMed ID: 18523404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
    Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
    J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Finding the optimal multiple-test strategy using a method analogous to logistic regression: the diagnosis of hepatolenticular degeneration (Wilson's disease).
    Richards RJ; Hammitt JK; Tsevat J
    Med Decis Making; 1996; 16(4):367-75. PubMed ID: 8912298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The copper/caeruloplasmin ratio in routine clinical practice in different laboratories.
    Twomey PJ; Wierzbicki AS; Reynolds TM; Viljoen A
    J Clin Pathol; 2009 Jan; 62(1):60-3. PubMed ID: 19103863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response of putative indices of copper status to copper supplementation in human subjects.
    Kehoe CA; Turley E; Bonham MP; O'Connor JM; McKeown A; Faughnan MS; Coulter JS; Gilmore WS; Howard AN; Strain JJ
    Br J Nutr; 2000 Aug; 84(2):151-6. PubMed ID: 11029965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.